Fulcrum Therapeutics

Home » Fulcrum Therapeutics

IPO

Fulcrum Therapeutics

Biopharmaceutical

We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Symbol

FULC

Price Range
$16.00 - $18.00

Final Shares
4,500,000

Anticipated Date
July 18, 2019

Underwriters
MORGAN STANLEY & CO. LLC,LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Fulcrum Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253